Healthcare & Life Sciences
Leyden Labs
Netherlandswww.leydenlabs.com/
Leyden Labs is a series a startup based in Netherlands. 6 investors tracked.
Activeseries-c-plus
series-c-plus
Stage
2018
Founded
5
Investors
About Leyden Labs
Leyden Labs is a startup founded in 2018 based in the Netherlands. Its most recent tracked round is Series C+. Brouky classifies it under Healthcare & Life Sciences. Brouky records 5 investors associated with the company.
Leyden Labs develops intranasal antibody sprays that target respiratory viruses at their point of entry, offering broad protection against influenza and coronavirus families by focusing on common viral characteristics.
Explore Leyden Labs's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.